FIELD: chemistry; biochemistry.
SUBSTANCE: invention relates to biotechnology, particularly to obtaining cell lines and can be used for immunotherapy and immunoprophylaxis in patients with malignant growths. The human melanoma cell line 26G has stable culture, morphological and immunological characteristics and can secrete a human recombinant granulocytic-macrophagal colony-stimulating factor (GM-CSF). The 26G cell line is deposited in the Special collection of cell cultures of cage vertebrates of the Russian collection of cell cultures under number RKKK (P) 701D. All cells of the 26G line are characterised by stable secretion of GM-CSF stored after inactivation of cells through exposure to 100 Gy of ionising radiation which reliably prevents proliferation of the inactivated cells.
EFFECT: invention enables introduction of inactivated tumour cells into patients in order to stimulate antitumuor immunity.
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN MELANOMA CELL LINE 31G WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395573C1 |
| HUMAN MELANOMA CELL LINE IG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395572C1 |
| HUMAN MELANOMA CELL LINE PG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395570C1 |
| HUMAN MELANOMA CELL LINE ILG WHICH SECRETES RECOMBINANT GRANULOCYTIC-MACROPHAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2395574C1 |
| LINE OF CELLS OF HUMAN MELANOMA KG, SECRETING RECOMBINANT GRANULOCYTIC MACROFAGAL COLONY-STIMULATING FACTOR | 2008 |
|
RU2362805C1 |
| METHOD FOR INCREASING IMMUNOGENICITY OF WHOLE-CELL ANTI-CANCER VACCINE | 2010 |
|
RU2458120C1 |
| IMMUNOSTIMULATOR INDUCING TUMOR-SPECIFIC IMMUNE CELLULAR RESPONSE AND METHOD FOR ITS PREPARING | 1996 |
|
RU2206329C2 |
| VACCINATION WITH USING IMMUNO-ISOLATED CELLS PRODUCING IMMUNOMODULATOR | 2016 |
|
RU2727697C2 |
| METHOD OF IMMUNOTHERAPY MALIGNANT TUMORS OF BRAIN | 2018 |
|
RU2686756C1 |
| METHOD OF IMMUNOTHERAPY WITH BONE-MARROW PRECURSORS OF DENDRITE CELLS, SENSIBILISED WITH PHOTOMODIFIED TUMOR CELLS IN VIVO, FOR PATIENTS DISSEMINATED WITH SOLID TUMORS | 2008 |
|
RU2376033C1 |
